Interstitial Lung Disease News

New data suggest that patients with symptomatic sarcoidosis are more likely to require treatment, have a greater number of organs involved in their disease and have worse health-related quality of life than their asymptomatic counterparts.

Just 32.1% of reproductive-age women with rheumatic diseases use any kind of prescription contraception, while at the same time more than 70% use at least one fetotoxic medication, according to findings published in Arthritis Care & Research.

Among rheumatologists, nephrologists and neurologists who issued more than 10 prescriptions for corticotropin in 2015, 88% received payments from its manufacturer — with more than 20% receiving more than $10,000 — despite the drug’s considerable cost and the dearth of evidence in support of its use, according to findings published in JAMA Network Open.

Significant, independent predictors of mortality for patients with cardiac sarcoidosis include age of 46 years or older and lack of an implanted pacemaker or defibrillator, according to recent study findings.

Occupational exposure to sarcoidosis appears to carry a higher risk for women than men, with the highest risks observed among black women in teaching, banking, administrative and metalwork, according to recent research.

Several factors — including age, race and geographic region of residence — appeared to influence a woman’s risk for sarcoidosis, according to study results.

A recent study found first-degree relatives and spouses of individuals with celiac disease have increased risk for nonceliac autoimmune diseases.

Weight gain and obesity in black women aged 21 to 69 years was linked with an increased risk for sarcoidosis, according to study results.

Sarcoidosis and polyarthritis were found to be prevalent in firefighters from New York City who worked at the World Trade Center after Sept. 11, 2001, and were more responsive to treatment with tumor necrosis factor inhibitors, according to recently published data.